Introduction
Despite the availability of HLA matching, routine cross-matching and potent immunosuppression, acute renal allograft rejection after kidney transplantation is still characterized by the recruitment of monocytes/macrophages, T and B lymphocytes and rapid deterioration of renal function [1, 2] . Subpopulations of inflammatory cells are guided towards specific renal microenvironments in a complex cascade of interactions between adhe-sion molecules, chemokines and chemokine receptors [3] [4] [5] . Furthermore, cell type-specific toll-like receptors (TLRs) were found to be important for the activation of chemokines and chemoattraction or priming of T cells [6] [7] [8] [9] .
TLRs are innate immune system receptors, which recognize specific molecular patterns present on invading microorganisms and thus are important in various kidney diseases [10, 11] . TLRs can also be activated by endogenous molecules [12, 13] , such as heat shock protein 60 or 70 [14] [15] [16] , fibronectin [17, 18] , soluble hyaluronan [19] [20] [21] and fibrinogen [22] . In a model of hepatic ischemiareperfusion injury (IRI), definitive evidence was found that endogenous TLR4 ligands are critical in the pathogenesis of liver IRI [23] . In a model of chronic allograft dysfunction, the functional relevance of TLR2/4 and their two major signaling pathways (MyD88 and TRIF) was demonstrated after endogenous incubation [24] . In a model of kidney IRI, a significant increase in TLR4 expression by tubular epithelial cells and infiltrating leukocytes was demonstrated [25] and it was shown that TLR4 acts as a sentinel for acute IRI-mediated renal damage [26] . Using a model of unilateral ureteral obstruction, it has recently been shown that TLR4-deficient mice displayed reduced fibrosis and that TLR4 blockade might be a therapeutic target for preventing renal fibrosis [27] .
In renal transplantation, most of the data focus on the role of TLR4 polymorphisms. In one study, renal transplant recipients with TLR4 polymorphism presented a lower risk of posttransplantation atherosclerotic events and acute allograft rejection if they received donor grafts heterozygous for the Asp299Gly or Thr399Ile TLR4 allele [28] . An additional study established the relevance of TLR4 polymorphisms in acute rejection of kidney transplants [29] .
However, in contrast to IRI, only few data exist about TLR4 expression, localization and activation of after allogeneic versus syngeneic kidney transplantation. We therefore used an experimental rat transplantation model of acute rejection to investigate the time course of TLR4 induction after kidney transplantation under standardized conditions. Our study was aimed at answering the following questions: (1) is TLR4 induction due to allogeneicity or to transplantation per se? (2) What are the time course and intrarenal localization of TLR4 expression? (3) Are endogenous ligands, such as fibrinogen, which are released during transplantation, potent activators of TLR4 and subsequent CC chemokine release, which is crucial for recruitment and enhancement of immune response by attraction of inflammatory cells?
Materials and Methods

Animals and Renal Transplantation
Animal experiments were performed following the NIH principles for laboratory animal care and the German laws on animal protection. Study approval was given by the inspecting authority (Regierung der Oberpfalz). Male Brown Norway rats served as donors and Lewis rats as recipients (Charles River Laboratories, Sulzfeld, Germany). The rats (200-250 g) were kept under conventional housing and diet conditions. Abbreviations, numbers, treatment regimens, histopathological diagnoses adapted to the Banff '97 classification for renal allograft damage and the corresponding renal function of the different groups are summarized in table 1 . Detailed protocols for renal transplantation have been previously published by our group [30, 31] . Briefly, allograft-dependent damage (Brown Norway rats as donors, Lewis rats as recipients) was compared with potential alterations after syngeneic transplantation (Lewis rats as donors and recipients) on postoperative days (PODs) 3, 6, 28. Cyclosporine (CsA, 5 mg/kg, Neoral; Novartis, Basel, Switzerland, administered once daily by gavage) was used as immunosuppression; naïve rats without CsA treatment served as controls. Additional alterations after unilateral nephrectomy with or without CsA treatment and IRI were performed (data not shown). During transplantation, the left kidneys were explanted, flushed with cold saline and transplanted orthotopically by endto-end anastomosis of the vessels and the ureter. Cold-and warmischemia times were approximately 35 and 30 min. Nephrectomy of both native kidneys was performed at the time of transplantation also in the syngeneic group. The transplanted groups were treated with CsA (KTx + CsA) or left without immunosuppression (KTx -CsA). The latter group only underwent the 6-day protocol. After euthanasia, the kidneys were divided into quarters and fixed in paraffin or snap-frozen in N 2 and stored at -80 ° C.
In the 6-day protocol, the rats were monitored in metabolic cages on PODs 0, 3 and 6 and in the 28-day experimental protocol, on PODs 0, 7, 14, 21 and 28. Histopathological diagnoses adapted to the Banff '97 classification [1] of the kidney specimens were made by renal pathologists.
RNA Isolation, Reverse Transcription and Real-Time PCR
Total RNA was extracted from frozen tissue sections in peq-GOLD TriFast (Peqlab, Erlangen, Germany) and reverse transcribed into cDNA as described before [30] . Primer sequences are listed in table 2 .
Immunohistochemistry
Immunohistochemistry was performed as previously described [32] . Sections were analyzed for TLR4 protein expression (monoclonal TLR4 antibody, Acris Antibodies GmbH, Hiddenhausen, Germany), CCL20 (polyclonal goat CCL20 antibody, Santa Cruz Biotechnology, Heidelberg, Germany), fibrinogen (polyclonal sheep fibrinogen antibody, AbDSeroTec, Düsseldorf, Germany), CD68 (monoclonal mouse antibody, AbDSeroTec, Düsseldorf, Germany), CD3 (polyclonal rabbit antibody, Abcam Cambridge, UK) and CD20 (polyclonal goat antibody, Santa Cruz Biotechnology). To further define the TLR4-positive cell population, paraffin-embedded allograft sections of transplanted rats were used for immunofluorescence as previously described [32] . 
Digital Imaging
For analysis of TLR4 expression, 10 high-power fields per specimen were examined by two different investigators (original magnification ! 400, covering an area of 296 m ! 222 m). Within these fields, the percentage of positive glomeruli among all detected glomeruli and positive tubuli among all detected tubuli were calculated for each specimen. We additionally noted, for each high-power field, whether positive staining was apparent in interstitia or in vessels. Mean and median values were calculated for each group.
Quantification of CCL20 Protein in Urine
Quantification of CCL20 protein in urine by Western blot analysis was performed as described before [31] . CCL20 was used as primary antibody (R&D Systems, Minneapolis, Minn., USA, MN55413 mouse IgG1 anti-rat CCL20, 2 g/ml) and binding of the primary antibody was visualized with a peroxidase-conjugated goat anti-mouse IgG-HRP secondary antibody (1: 5,000, Santa Cruz Biotechnology).
Statistical Analysis
Values are provided as means 8 SEs. Statistical analysis was performed by the nonparametric Mann-Whitney U test and by univariate ANOVA. p ! 0.05 was considered to be statistically significant.
Results
Clinical and Histopathological Characterization of the Different Experimental Groups
KTx + CsA rats displayed serum creatinine levels almost twice as high as those of controls (Banff 1 = normal) and moderate histopathological changes with typical signs of rejection on POD day 6 (Banff 4 IA = interstitial infiltration 1 25% of parenchyma affected and foci of moderate tubulitis) ( table 1 ). On POD 6, syngeneic transplantated (synKTx) rats displayed slightly elevated creatinine levels without histopathological changes (Banff 1) compared to control rats. In contrast, KTx -CsA showed severely elevated serum creatinine levels on POD 6 and signs of severe Table 1 . Experimental renal transplantation model in rats in a 6-day and a 28-day protocol: numbers of rats, histopathological classification and serum creatinine concentrations of the different groups Table 2 . Primer sequences (r = rat) Gene Forward primer Reverse primer 
TLR4 mRNA Induction in an Experimental Kidney Transplantation Model
Compared to controls, significantly upregulated TLR4 mRNA expression was only seen in KTx + CsA (p = 0.02) and KTx -CsA (p = 0.008) rats on POD 6 ( fig. 1 ). TLR4 mRNA expression in KTx -CsA rats was significantly higher than in KTx + CsA rats (p = 0.004). In contrast, syngeneic transplantation did not alter TLR4 expression Immunohistochemistry. In control and synKTx rats, the most prominent TLR4 staining was observed in the proximal tubuli. There was no positive staining in glomeruli. In KTx + CsA rats, upregulation of TLR4 expression was also seen in the glomerular compartment (red arrows, black in the printed version) (mesangial cells, podocytes) and in the interstitium (green arrows, white in the printed version), which was more pronounced in KTx -CsA rats. Original magnification ! 400.
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Nephron Exp Nephrol 2012;121:e59-e70 e63 either on POD 6 or on POD 28. On POD 28, TLR4 mRNA expression in KTx + CsA rats was still upregulated (1.4-fold; p = 0.05) in comparison with control rats, but the expression was significantly lower than on POD 6 (p = 0.03) ( fig. 1 ). On POD 3, a 2.5-fold TLR4 induction was seen in KTx + CsA rats (p = 0.04), which was quite similar to that in synKTx rats (2.2-fold TLR4 induction; p = 0.04) and IRI-treated rats (2.85-fold TLR4 induction; p = 0.03; data not shown). However, no other alteration (i.e. unilateral nephrectomy with or without CsA or IRI) significantly influenced TLR4 expression on POD 6 or 28 (data not shown).
Localization and Quantification of TLR4 Induction by Immunohistochemistry
On POD 6 and 28, there was a prominent TLR4 staining in arterial vessel walls in all groups whereas no TLR4 staining could be detected in veins. In kidneys of control rats and synKTx rats, TLR4 staining was restricted to the proximal tubuli within the cortex and the outer medullary stripe. With the exception of the visceral/parietal aspects of Bowman's capsule, TLR4 expression was absent in glomeruli or the inner medulla ( fig. 2 ). In contrast, KTx + CsA rats displayed a milder TLR4 staining in glomeruli and in the interstitium ( fig. 2 ) . KTx -CsA ( fig. 3 a) . On POD 28, KTx + CsA rats still showed significantly elevated glomerular TLR4 expression in comparison to control rats ( fig. 3 a) . In contrast, all examined groups displayed a similar tubular TLR4 staining pattern without significant differences either on POD 6 or 28 ( fig. 3 b) .
Quantification of Infiltrating Cell
Populations to the Graft CD3, CD20 and CD68 mRNA expression was examined in total kidney homogenates of all groups on POD 6 and 28. In total kidney homogenates, CD3, CD20 and CD68 mRNA expression was significantly elevated in KTx + CsA (p ! 0.01) and KTx -CsA rats (p ! 0.001) on POD 6, compared to control and in contrast to synKTx rats ( fig. 4 a) . On POD 28, significantly elevated CD20 and CD68 expression was still found in KTx + CsA rats (p ! 0.01). Additional analysis of relative CD68-positive staining in the different groups by Meta View software confirmed these data: control on POD 6: 2.00%; synKTx 10.78%; KTx 8 CsA on POD 6: 74.41%, KTx 8 CsA on POD 28: 23.59% (data not shown).
To further specify the TLR4-positive cell population, we stained serial slides for TLR4 and CD3, CD20 and CD68 and performed double immunofluorescence: TLR4 was mainly expressed on CD68-positive monocytes/ macrophages ( fig. 4 b) . 
Chemokine Expression in the Allograft
We detected a significant increase in CCL2 and CCL20 mRNA expression in KTx + CsA (p ! 0.001) and KTxCsA rats (p ! 0.01) on POD 6 ( fig. 5 a) compared to controls. CCL2 expression in KTx -CsA was significantly higher than in KTx + CsA (p = 0.01). On POD 28, both CC chemokines reached baseline levels without any significant differences. On POD 6, CCL2 and CCL20 mRNA were moderately upregulated in synKTx rats (p = 0.04). Besides CCL20, its receptor CCR6 was also significantly upregulated in KTx + CsA (p = 0.005) and KTx -CsA rats (p = 0.0007) on POD 6 (data not shown), with significantly higher CCR6 expression in KTx -CsA rats (p = 0.02). CCR6 expression in KTx + CsA rats was still sig- Using immunohistochemistry, we found that in control, but also in synKTx animals, positive CCL20 staining on POD 6 as well as on POD 28 was restricted to Bowman's capsule and some vascular endothelial cells. In contrast, prominent accumulation of CCL20-positive cells was detected mainly in interstitial infiltrates and in the glomerular compartment of KTx + CsA and KTx -CsA rats ( fig. 5 a) . Serial slides confirmed that CCL20 expression colocalized with TLR4-positive cells.
Western Blot Analysis of Urinary CCL20 Excretion
In comparison with control rats, we detected a marked increase in CCL20 protein in the urine of KTx + CsA and KTx -CsA rats already on POD 3 ( fig. 5 b) . Urinary CCL20 protein of KTx -CsA rats was markedly higher than in KTx + CsA rats and these differences were even more pronounced on POD 6. On POD 28, we compared control 8 CsA with KTx + CsA rats and detected only a slight increase in urinary CCL20 protein level in KTx + CsA rats.
Fibrinogen Deposition after Allogeneic Kidney
Transplantation A significant increase in fibrinogen-␤ and -␥ mRNA expression in KTx 8 CsA rats was found on POD 6 com- 6 ). The expression level of fibrinogen-␥ was significantly higher in KTx + CsA rats. In synKTx rats, there was only a trend towards increased fibrinogen-␤ and -␥ expression. On POD 28 after allogeneic transplantation, fibrinogen-␤ and -␥ deposition was still significantly upregulated; however, in comparison with POD 6, a significant decrease was found (p = 0.002). The immunohistochemical findings were in accordance with the detected mRNA expression levels. In allografts of the transplanted rats, a marked increase in fibrinogen-positive staining in the peritubular arteries within glomeruli and interstitial infiltrates could be demonstrated mainly in the KTx -CsA group. In serial slides, fibrinogen deposition matched with TLR4 staining, especially in the glomerular, periglomerular and peritubular parts (data not shown). In synKTx rats, only mild fibrinogen staining was found (data not shown).
Discussion
In the present study, we examined the time course and localization of TLR4 after experimental kidney transplantation, correlated these data with renal function and further focused on functional consequences of TLR4 activation. Significantly induced TLR4 mRNA expression was found only after allogeneic transplantation. TLR4 mRNA expression was elevated on POD 6 and decreased towards POD 28 in KTx 8 CsA.
Immunohistochemistry displayed high but unmodified TLR4 protein expression in renal tubular cells and highly inducible TLR4 staining within glomeruli in KTx 8 CsA rats. These rats also displayed tubulointerstitial infiltrates with TLR4-positive cells and immunofluorescence characterized these cells mainly as CD68-positive macrophages. Whereas TLR4 expression on tubular cells was previously reported to be important during ascending urinary infections [33] , our finding of upregulated TLR4 within glomeruli in renal allogeneic, but not syngeneic transplants is new. Both intrinsic renal cells (e.g. mesangial cells, podocytes and vascular endothelial cells) and infiltrating macrophages seem to contribute to TLR4 expression in allograft rejection. The expression profile of infiltrating cells within the allografts with an ongoing CD20/68 pattern typically for B-cells and macrophages on POD 28 in KTx + CsA rats as well as the CD68-TLR4 double staining proving the presence of TLR4-positive macrophages favors the importance of infiltrating cells for TLR4 expression. However, immunohistochemical data on TLR4 induction not only in the interstitial but also within the glomerular compartment stress the importance of renal intrinsic cells after acute rejection for ongoing TLR4 induction. The relevance of infiltrating and intrinsic renal cells to TLR4 induction after acute rejection still lacks clarity.
Continuative experiments in an IRI mouse model with chimeric mice suggested that TLR4 signaling in intrinsic more than infiltrating cells plays a crucial role in renal damage after kidney ischemia for 22 min [25] . Additional work by Leemans et al. [34] with chimeric mice also postulated that TLR2 expressed on the renal parenchyma plays a crucial role in the induction of inflammation and injury after IRI. TLR4 is considered as a key molecule of innate immunity involved in cell survival as well as IRI, where it has been intensively examined [25, 26, 35, 36] . As the ischemia times were short in our model (35 min of cold and 30 min of warm ischemia time), a significant contribution of IRI to TLR4 expression beyond POD 5 should be limited because renal TLR4 expression after allogeneic transplantation displayed a different time course: whereas TLR4 expression due to IRI is seen at earlier time points (POD 3) and disappears or is much lower on POD 5 [25, 26] , we observed a peak of TLR4 expression on POD 6 with decreasing TLR4 expression on POD 28.
Thus, the impact of IRI on TLR4 expression levels in our renal transplantation model might be lower than the contribution of intrinsic renal-and graft-infiltrating CD68-positive macrophages. This is stressed by the similar TLR4 induction in KTx + CsA, KTx -CsA, synKTx and IRI-treated rats on POD 3 and the striking differences at later time points, where allogeneic transplantation seems to be a sustained trigger. TLR4 induction correlated with both renal function and local chemokine synthesis: TLR4 activation was accompanied by marked induction of CCL2 and CCL20. Both chemokines were significantly upregulated in renal allografts, especially in allograft rejection. These data are in line with the finding that TLR4 is linked to the expression of proinflammatory cytokines and chemokines [25] . Chemokines like CCL2 are known to recruit and activate leukocytes [37] and thus can mediate allograft rejection [38] [39] [40] . The relevance of CCL2 was already underlined by data showing that high levels of donor-derived CCL2 are associated with poor outcome in murine islet transplantation [41] and by findings on the differences in CCL2 expression between allografts and isografts 7 days after islet transplantation. The parallel induction of TLR4 and CCL2/CCL20 after allogeneic transplantation in a model of acute rejection stresses the relevance of these data because markedly increased CCL2 expression was also seen in human renal allografts with acute rejection [42] . CCL20 was not only induced within the kidney but was also excreted into the urine of transplanted rats in amounts that correlate with the severity of allograft rejection. Therefore, transplanted rats with almost normal renal function and without significant allograft rejection on POD 28 only showed a slight increase in CCL20 urinary protein concentration. These data support previous findings suggesting that CCL20 is as a sensitive urinary marker of allograft rejection [43, 44] . Because of the induction of CCL2 and CCL20 chemokines after TLR4 induction and their known role for recruitment and enhancement of immune response by attraction of inflammatory cells monitoring, TLR4 expression may be a useful tool for monitoring renal function and a novel marker of acute rejection. However, one study analyzing human allograft biopsies for TLR4 staining could not correlate TLR4 expression and renal function [45] . One explanation for this discrepancy might be the time course of TLR4 expression after kidney transplantation. In our model, TLR4 expression peaked on POD 6 and the other study analyzed protocol biopsies from human allografts at least 6 weeks after transplantation.
So far, our data demonstrate that TLR4 and CCL2 and CCL20 induction was restricted to the KTx groups. These data were analyzed in an acute rejection model whereas data on the relevance of TLR4 expression and chronic allograft dysfunction (CAD) have been intensively studied in a mouse model [24] . Wang et al. [31] showed that the innate immune system, and especially TLR2 and TLR4, is involved in CAD development. We also examined the contribution of TLR2 in an acute rejection model and found marked upregulation of TLR2 after experimental renal transplantation, an observation that was confirmed in acute rejection of human allografts. In contrast, no induction of other TLRs typically expressed intracellularly, such as TLR3 or TLR9, was detected.
Influx of CD68-positive macrophages could be found in synKTx rats only by immunohistochemical software analysis whereas KTx rats not only displayed a brighter staining degree but also induced mRNA expression. These data are in line with a previous study that demonstrated significantly higher TLR4 expression on circulating monocytes in patients with acute rejection after liver transplantation [46] .
Additional experiments were designed to test the role of the endogenous TLR4 ligand fibrinogen. We found significantly induced fibrinogen deposition (in peritubular arteries, within the glomeruli and interstitial infiltrates) matching TLR4 localization as shown by serial slides. Additionally, we were able to detect significantly induced local fibrinogen mRNA synthesis after allogeneic transplantation. We have previously demonstrated in cultured podocytes that fibrinogen is a potent TLR4 activator, and that podocytes release chemokines after fibrinogen incubation in a TLR4-dependent manner [47] , a mechanism potentially important for other renal cell types as well. The time course of fibrinogen expression in our kidney transplantation model was in accordance with an experimental cardiac transplantation model, in which expression of fibrinogen-like protein 2 peaked at day 7 [48] . The relevance of fibrinogen deposition after human kidney transplantation was previously demonstrated [49] . Besides these transplantation models, the substantial contribution of fibrinogen was characterized in different models of glomerulonephritis [50] [51] [52] [53] . The significantly induced fibrinogen mRNA synthesis after allogeneic transplantation might be regarded as a hint for an ongoing contribution of fibrinogen to allograft damage in an acute rejection model.
In summary, after experimental kidney transplantation, TLR4 expression was found be induced in the allogeneic setting, but not by transplantation per se and in a time course rather different from that after IRI. TLR4 expression correlated with renal allograft function and subsequent CC chemokine expression in the graft as well with CC chemokine release into the urine. Early activation of TLR4 by fibrinogen as part of innate immunity could be the first response to tissue injury prior to activation of the adaptive immune system [54, 55] .
